Medical calcium lime

Abstract

The utility model relates to the technical field of medical calcium lime, in particular to medical calcium lime, and solves the problems of relatively less technical innovation and serious product homogenization of the current medical calcium lime in the prior art. And due to the lack of a core technology, the medical calcium lime in the market is difficult to have great breakthrough in performance and quality, so that the problem that benign growth is difficult to achieve in the market is solved. The medical calcium lime comprises a calcium lime model, the calcium lime model further comprises a bioactive molecular layer and a drug controlled release layer, an anticoagulant molecular layer is arranged at the bottom of the drug controlled release layer, and a hydrophilic and hydrophobic layer is arranged at the bottom of the anticoagulant molecular layer. According to the utility model, cell adhesion, proliferation and differentiation are promoted, wound healing and tissue regeneration are facilitated, and slow release of drugs is realized, so that the effect of continuous treatment is achieved, the hydrophilic layer can improve wettability with body fluid, and the hydrophobic layer is helpful for preventing liquid permeation, so that the market competitiveness is increased.

Description

Technical Field

[0001] The utility model relates to the technical field of medical calcium lime, in particular to medical calcium lime. Background Art

[0002] Medical lime, also known as medical calcium hydroxide or medical calcium agent, is a chemical substance used specifically in the medical field. It is mainly composed of calcium hydroxide, and sometimes also contains ingredients such as calcium chloride, and is designed to absorb acidic gases such as carbon dioxide. This substance plays an important role in the anesthesia breathing circuit, and can effectively absorb the carbon dioxide exhaled by the patient, thereby maintaining the patency of the airway.

[0003] In the existing technology, the current technical innovation of medical calcium lime is relatively small, and the product homogeneity is serious. The lack of core technology makes it difficult for medical calcium lime on the market to have a major breakthrough in performance and quality, making it difficult to achieve healthy growth in the market. Hereby a medical calcium lime is proposed. Utility Model Content

[0004] The purpose of the utility model is to provide a medical calcium lime, which solves the problem that the current medical calcium lime in the prior art has relatively few technical innovations and serious product homogeneity. The lack of core technology makes it difficult for the medical calcium lime on the market to have a major breakthrough in performance and quality, making it difficult to achieve healthy growth in the market.

[0005] In order to achieve the above purpose, the utility model adopts the following technical solutions:

[0006] A medical calcium lime comprises a calcium lime model, wherein the calcium lime model further comprises a bioactive molecule layer and a drug controlled release layer, wherein an anticoagulant molecule layer is arranged at the bottom of the drug controlled release layer, wherein a hydrophilic-hydrophobic layer is arranged at the bottom of the anticoagulant molecule layer, wherein a nano material layer is arranged at the bottom of the hydrophilic-hydrophobic layer, and wherein a temperature-sensitive pH response layer is arranged at the bottom of the nano material layer.

[0007] Preferably, the top of the temperature-sensitive pH response layer is connected to the top of the nanomaterial layer by glue.

[0008] Preferably, the top of the nano material layer is connected to the bottom of the hydrophilic and hydrophobic layer by glue.

[0009] Preferably, the top of the hydrophilic-hydrophobic layer and the bottom of the anti-blood coagulation molecule layer are connected by glue.

[0010] Preferably, the top of the anti-blood coagulation molecule layer and the bottom of the drug controlled-release layer are connected by glue.

[0011] Preferably, the bottom of the bioactive molecule layer and the top of the drug controlled-release layer are connected by glue.

[0012] The utility model has at least the following beneficial effects:

[0013] By setting up a bioactive molecular layer, cell adhesion, proliferation and differentiation can be promoted, which helps wound healing and tissue regeneration. By setting up a drug controlled release layer, drug molecules can be embedded into the surface of the calcium lime to achieve slow release of the drug, thereby achieving a continuous therapeutic effect. By setting up an anticoagulant molecular layer, the risk of blood coagulation on the surface of medical calcium lime can be reduced by adding anticoagulants such as heparin, which is particularly important in certain surgical operations. By setting up a hydrophilic-hydrophobic layer, the hydrophilic layer can improve the wettability with body fluids, while the hydrophobic layer helps prevent liquid penetration. By setting up a nanomaterial layer, the antibacterial effect can be enhanced or other special functions can be imparted, such as enhancing the photothermal effect for photothermal therapy, thereby increasing market competitiveness. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] In order to more clearly illustrate the technical solutions of the embodiments of the utility model, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are some embodiments of the utility model. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0015] Figure 1 It is a schematic diagram of the structure of the utility model;

[0016] Figure 2 The utility model is a schematic diagram of the internal structure of the lime model.

[0017] In the figure: 1, calcium lime model; 101, bioactive molecule layer; 102, drug controlled release layer; 103, anticoagulant molecule layer; 104, hydrophilic and hydrophobic layer; 105, nanomaterial layer; 106, thermosensitive pH response layer. DETAILED DESCRIPTION

[0018] In order to make the purpose, technical solution and advantages of the utility model more clear, the utility model is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the utility model and are not used to limit the utility model.

[0019] Reference Figure 1-2A medical calcium lime comprises a calcium lime model 1, wherein the calcium lime model 1 further comprises a bioactive molecule layer 101 and a drug controlled release layer 102, wherein an anticoagulant molecule layer 103 is disposed at the bottom of the drug controlled release layer 102, wherein a hydrophilic-hydrophobic layer 104 is disposed at the bottom of the anticoagulant molecule layer 103, wherein a nanomaterial layer 105 is disposed at the bottom of the hydrophilic-hydrophobic layer 104, wherein a thermosensitive pH response layer 106 is disposed at the bottom of the nanomaterial layer 105, wherein the bioactive molecule layer 101 is disposed to promote cell adhesion, proliferation and differentiation, thereby facilitating wound healing and tissue regeneration, and wherein the drug controlled release layer 102 ... The setting of the release layer 102 can embed drug molecules into the surface of the calcium lime to achieve slow release of the drug, thereby achieving a continuous therapeutic effect. The setting of the anticoagulant molecule layer 103 and the addition of anticoagulants, such as heparin, can reduce the risk of blood coagulation on the surface of the medical calcium lime, which is particularly important in certain surgical operations. The setting of the hydrophilic-hydrophobic layer 104 can improve the wettability with body fluids, while the hydrophobic layer helps prevent liquid penetration. The setting of the nanomaterial layer 105 can enhance the antibacterial effect or impart other special functions, such as enhancing the photothermal effect for photothermal therapy.

[0020] This program has the following working process:

[0021] By setting up the bioactive molecule layer 101, cell adhesion, proliferation and differentiation are promoted, which helps wound healing and tissue regeneration. By setting up the drug controlled release layer 102, drug molecules can be embedded into the surface of the calcium lime to achieve slow release of the drug, thereby achieving a continuous treatment effect. By setting up the anticoagulant molecule layer 103, by adding anticoagulants such as heparin, the risk of blood coagulation on the surface of medical calcium lime can be reduced, which is particularly important in certain surgical operations. By setting up the hydrophilic-hydrophobic layer 104, the hydrophilic layer can improve the wettability with body fluids, while the hydrophobic layer helps prevent liquid penetration. By setting up the nanomaterial layer 105, the antibacterial effect can be enhanced or other special functions can be imparted, such as enhancing the photothermal effect for photothermal therapy.

[0022] According to the above working process, we can know that:

[0023] It promotes cell adhesion, proliferation and differentiation, helps wound healing and tissue regeneration, and achieves slow release of drugs, thereby achieving a sustained therapeutic effect. The hydrophilic layer can improve the wettability with body fluids, while the hydrophobic layer helps prevent liquid penetration, increasing market competitiveness.

[0024] Furthermore, the top of the temperature-sensitive pH response layer 106 is connected to the top of the nanomaterial layer 105 by glue.

[0025] Furthermore, the top of the nano material layer 105 is connected to the bottom of the hydrophilic and hydrophobic layer 104 by glue.

[0026] Furthermore, the top of the hydrophilic / hydrophobic layer 104 and the bottom of the anti-blood coagulation molecule layer 103 are connected by glue.

[0027] Furthermore, the top of the anti-blood coagulation molecule layer 103 and the bottom of the drug controlled-release layer 102 are connected by glue.

[0028] Furthermore, the bottom of the bioactive molecule layer 101 and the top of the drug controlled-release layer 102 are connected by glue.

[0029] The above shows and describes the basic principle, main features and advantages of the utility model. Those skilled in the art should understand that the utility model is not limited by the above embodiments. The above embodiments and the specification only describe the principles of the utility model. The utility model may be subject to various changes and improvements without departing from the spirit and scope of the utility model. These changes and improvements fall within the scope of the utility model to be protected. The scope of protection claimed by the utility model is defined by the attached claims and their equivalents.

Claims

1. A medical limestone, comprising a limestone model (1), characterized in that: The calcium lime model (1) further comprises a bioactive molecule layer (101) and a drug controlled release layer (102); an anticoagulant molecule layer (103) is arranged at the bottom of the drug controlled release layer (102); a hydrophilic-hydrophobic layer (104) is arranged at the bottom of the anticoagulant molecule layer (103); a nano material layer (105) is arranged at the bottom of the hydrophilic-hydrophobic layer (104); and a temperature-sensitive pH response layer (106) is arranged at the bottom of the nano material layer (105).

2. A medical calcium lime according to claim 1, characterized in that: The top of the temperature-sensitive pH response layer (106) is connected to the top of the nanomaterial layer (105) by glue.

3. The medical calcium lime according to claim 1, characterized in that: The top of the nano material layer (105) is connected to the bottom of the hydrophilic and hydrophobic layer (104) by glue.

4. The medical calcium lime according to claim 1, characterized in that: The top of the hydrophilic / hydrophobic layer (104) and the bottom of the anti-blood coagulation molecule layer (103) are connected by glue.

5. The medical calcium lime according to claim 1, characterized in that: The top of the anti-blood coagulation molecule layer (103) and the bottom of the drug controlled-release layer (102) are connected by glue.

6. The medical calcium lime according to claim 1, characterized in that: The bottom of the bioactive molecule layer (101) and the top of the drug controlled release layer (102) are connected by glue.

Images